HUE048570T2 - (S) 2-N (3-O-(propán 2-OL)-1-propil-4-hidrobenzol)-3-fenilpropilamid izolált szereoizomer alakjai - Google Patents

(S) 2-N (3-O-(propán 2-OL)-1-propil-4-hidrobenzol)-3-fenilpropilamid izolált szereoizomer alakjai

Info

Publication number
HUE048570T2
HUE048570T2 HUE12855522A HUE12855522A HUE048570T2 HU E048570 T2 HUE048570 T2 HU E048570T2 HU E12855522 A HUE12855522 A HU E12855522A HU E12855522 A HUE12855522 A HU E12855522A HU E048570 T2 HUE048570 T2 HU E048570T2
Authority
HU
Hungary
Prior art keywords
phenylpropylamide
hydroxybenzene
propan
propyl
stereoisomeric forms
Prior art date
Application number
HUE12855522A
Other languages
English (en)
Hungarian (hu)
Inventor
Eliahu Kaplan
Original Assignee
Novaremed Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novaremed Ltd filed Critical Novaremed Ltd
Publication of HUE048570T2 publication Critical patent/HUE048570T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/22Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUE12855522A 2011-12-08 2012-12-06 (S) 2-N (3-O-(propán 2-OL)-1-propil-4-hidrobenzol)-3-fenilpropilamid izolált szereoizomer alakjai HUE048570T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161568219P 2011-12-08 2011-12-08

Publications (1)

Publication Number Publication Date
HUE048570T2 true HUE048570T2 (hu) 2020-08-28

Family

ID=48573665

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE12855522A HUE048570T2 (hu) 2011-12-08 2012-12-06 (S) 2-N (3-O-(propán 2-OL)-1-propil-4-hidrobenzol)-3-fenilpropilamid izolált szereoizomer alakjai

Country Status (11)

Country Link
US (1) US9381173B2 (https=)
EP (1) EP2788317B1 (https=)
JP (2) JP6411893B2 (https=)
CN (1) CN103998420B (https=)
AU (1) AU2012348529B2 (https=)
CA (1) CA2856665C (https=)
DK (1) DK2788317T3 (https=)
ES (1) ES2763946T3 (https=)
HU (1) HUE048570T2 (https=)
IN (1) IN2014MN00919A (https=)
WO (1) WO2013084238A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015173813A1 (en) * 2014-05-14 2015-11-19 Novaremed Ltd. Pharmaceutical composition comprising stereoisomers of n-(1-(4-hydroxyphenyl)-3-(2-hydroxypropoxy)propan-2-yl)-3-phenylpropanamide for the prevention and treatment of type ii diabetes
KR102062268B1 (ko) 2018-05-18 2020-01-03 한국교통대학교 산학협력단 발광 특성 또는 전하 전달 특성이 우수한 아지드계 가교제
CN113329746B (zh) * 2019-01-23 2025-05-02 诺瓦麦有限公司 用于治疗或预防疼痛、炎症和/或自身免疫的化合物
EP3939578A1 (en) 2020-07-13 2022-01-19 Novaremed Ltd. Compounds for treatment or prevention of an infection resulting from a coronavirus and/or a coronavirus-induced disease
WO2026037478A1 (en) 2023-08-11 2026-02-19 Novaremed AG (s,s)-(3-o-(propan-2-ol)-2-amino-prop-1-yl-4-hydroxybenzene and its analogues for the treatment of chronic pain

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1546088B1 (en) 2002-10-03 2014-12-17 Novaremed Ltd. Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
JP4939396B2 (ja) 2004-03-26 2012-05-23 ノヴァレメッド リミテッド Aids及び他のウイルス性疾患及びhiv関連感染症の改善又はその治療用化合物及びそのような化合物を含む組成物、そのような疾患及び感染症の治療方法及びそのような化合物及び組成物の製造方法
US20090197781A1 (en) 2008-01-31 2009-08-06 Hari Babu Sunkara Wellbore Fluids Comprising Poly(trimethylene ether) glycol Polymers
GB0804213D0 (en) * 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
US8802734B2 (en) * 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
EP2475361B1 (en) 2009-09-09 2019-11-06 Novaremed Ltd. N-substituted benzenepropanamides for use in the treatment of pain and inflammation
GB0916073D0 (en) 2009-09-14 2009-10-28 Cintec Int Ltd Improvements in and relating to building anchor systems

Also Published As

Publication number Publication date
AU2012348529B2 (en) 2017-03-30
HK1201059A1 (en) 2015-08-21
EP2788317B1 (en) 2019-10-02
WO2013084238A1 (en) 2013-06-13
DK2788317T3 (da) 2020-01-20
JP2015500831A (ja) 2015-01-08
EP2788317A4 (en) 2015-07-08
US9381173B2 (en) 2016-07-05
IN2014MN00919A (https=) 2015-04-17
CA2856665A1 (en) 2013-06-13
CN103998420A (zh) 2014-08-20
US20140275270A1 (en) 2014-09-18
JP2018021023A (ja) 2018-02-08
ES2763946T3 (es) 2020-06-01
AU2012348529A1 (en) 2014-06-12
JP6411893B2 (ja) 2018-10-31
CN103998420B (zh) 2018-04-17
CA2856665C (en) 2019-11-12
EP2788317A1 (en) 2014-10-15

Similar Documents

Publication Publication Date Title
EP2667925A1 (en) Reinforced balloon catheter
AU338052S (en) Goggles
PL2704909T3 (pl) Dętka koła
DE112012001116T8 (de) Überformtes Radauswuchtgewicht
EP2780902A4 (en) PILOTAGE DRIVE SYSTEM
IL232323A0 (en) Reduction of galectin-3 levels through blood filtration
GB201222832D0 (en) Manufacture of hollow parts
HUE048570T2 (hu) (S) 2-N (3-O-(propán 2-OL)-1-propil-4-hidrobenzol)-3-fenilpropilamid izolált szereoizomer alakjai
EP2742358A4 (en) METHOD FOR THE DIAGNOSIS OF CANCER
ZA201200281B (en) Human-manchine dialog system
GB201112871D0 (en) Landing string
ZA201500488B (en) Manufacture of wheels
ZA201308101B (en) Diagnostic use of prosomatostatin
GB2491178B (en) Asthma spacer
GB2483734B (en) Landing gear
IL232754A0 (en) Isolated isomeric forms of (s) 2–n(3–o–(propan 2–ol)–1–propyl–4–hydroxybenzene)–3–phenylpropylamide
GB2489742B (en) Swim goggles
GB201103980D0 (en) Exercise tube
GB2497504B (en) Amphibian
GB2483187B (en) Goggles
GB201102243D0 (en) Prodrugs of guanfacine
GB201100981D0 (en) Prodrugs of guanfacine
GB201108405D0 (en) Wearable medical training aid
AU2012903358A0 (en) Swim straight
GB201111801D0 (en) Improved cockpit instrument